Cowen and Company’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-801,298
| Closed | -$970K | – | 544 |
|
|
2024
Q2 | $970K | Sell |
801,298
-58,845
| -7% | -$71.2K | 0.03% | 145 |
|
|
2024
Q1 | $2.02M | Sell |
860,143
-1,855,135
| -68% | -$4.36M | 0.08% | 120 |
|
|
2023
Q4 | $5.13M | Hold |
2,715,278
| – | – | 0.34% | 50 |
|
|
2023
Q3 | $3.72M | Sell |
2,715,278
-119,586
| -4% | -$164K | 0.26% | 70 |
|
|
2023
Q2 | $6.89M | Sell |
2,834,864
-308,744
| -10% | -$750K | 0.57% | 42 |
|
|
2023
Q1 | $18.1M | Hold |
3,143,608
| – | – | 2.13% | 13 |
|
|
2022
Q4 | $28.1M | Buy |
3,143,608
+700,362
| +29% | +$6.26M | 2.94% | 9 |
|
|
2022
Q3 | $34.7M | Sell |
2,443,246
-534
| -0% | -$7.59K | 3.32% | 7 |
|
|
2022
Q2 | $35.7M | Buy |
2,443,780
+943,725
| +63% | +$13.8M | 3.45% | 5 |
|
|
2022
Q1 | $30M | Buy |
+1,500,055
| New | +$30M | 2.88% | 8 |
|